PFF Webinar Library

fda-stamp-of-approval-and-medications

The FDA's Drug Approval Process

Fri, Sep 28, 2018

Learn about FDA requirements for drug approval, frequently used FDA terminology, and therapies for IPF.

Dr. Banu Karimi-Shah of the FDA - Center for Drug Evaluation and Research, Division of Pulmonary, Allergy, and Rheumatology Products joins us to give background information on the FDA requirements for drug approval, frequently used FDA terminology, and therapies for IPF.

Recent Webinars

  • Sep
    10
    2025

    Genetics and Beyond: Exploring Interstitial Lung Disease in Families and Individuals | Virtual

    View Webinar
  • Aug
    27
    2025

    Building the Evidence Pyramid: What Makes Research Reliable? | Virtual

    View Webinar
  • Jul
    23
    2025

    Managing Pulmonary Hypertension and Interstitial Lung Disease: Symptoms, Tests, and Treatment

    View Webinar
  • Jun
    25
    2025

    Understanding Mold-Related Hypersensitivity Pneumonitis: Diagnosis, Treatment, and Remediation

    View Webinar